Papers matching “pharmacokinetics” in Treatment of Major Depression 10
Not finding it? Sign in to also search OpenAlex live.
-
Pharmacokinetics and pharmacodynamics of intravenous and oral (S)‐ketamine: Investigating metabolite contribution to subjective effects2026 British Journal of Clinical Pharmacology article Medicine Treatment of Major Depression Open access
Marije E. Otto, Gabriël E. Jacobs, Joost van Mechelen, Laura G. J. M. Borghans, Johan G.C. van Hasselt, Linda B. S. Aulin
0citations -
Pharmacological characterization of orally and intravenously administered (S-)ketamine in healthy humans: an apparent crucial role for (S-)ketamine and not its pharmacologically active metabolite (S-)norketamine in mediating acute NMDAR central nervous system effects up to 6 hours
Joost van Mechelen, Tobias Wieles, Laura G. J. M. Borghans, Maria Joanna Juachon, Amy L. Gillespie, Martijn S. van Noorden, +4 more
0citations -
Nitric Oxide Donor Sodium Nitroprusside Reduces Racemic Ketamine─But Not Esketamine-Induced Pain Relief2024 ACS Pharmacology & Translational Science article Medicine Treatment of Major Depression Open access
Albert Dahan, Simone C. Jansen, Rutger M. van der Schrier, Elise Y. Sarton, David Dadiomov, Monique van Velzen, +2 more
9citations
10 results